Institutional Ownership Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX). We have compiled data on the 142 institutions that hold shares in the stock, with a total of 75.8 Million shares, which have been reported (via 13F filing form) to have a value of $797 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
8,800,000
shares
|
$92.5 Million
0.1% of portfolio
|
Q2 2025
Added 54.45%
|
|
Perceptive Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
7,902,365
shares
|
$83.1 Million
2.22% of portfolio
|
Q2 2025
Added 0.36%
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
5,943,812
shares
|
$62.5 Million
7.77% of portfolio
|
Q1 2025
Added 27.99%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
4,536,266
shares
|
$47.7 Million
0.07% of portfolio
|
Q2 2025
Added 394.7%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
4,498,028
shares
|
$47.3 Million
0.0% of portfolio
|
Q2 2025
Added 9.27%
|
|
Saturn V Capital Management LLC
Austin, TX |
Aug 13, 2025 Q2 2025 |
3,260,570
shares
|
$34.3 Million
8.47% of portfolio
|
Q2 2025
Added 34.38%
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Aug 14, 2025 Q2 2025 |
2,934,405
shares
|
$30.8 Million
0.82% of portfolio
|
Q1 2025
Added 102.07%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,669,741
shares
|
$28.1 Million
0.0% of portfolio
|
Q2 2024
Reduced 40.34%
|
|
683 Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
2,160,000
shares
|
$22.7 Million
1.08% of portfolio
|
Q2 2025
Reduced 10.43%
|
|
Almitas Capital LLC
Santa Monica, CA |
Aug 14, 2025 Q2 2025 |
2,122,597
shares
|
$22.3 Million
6.42% of portfolio
|
Q1 2025
Added 4.44%
|
|
Great Point Partners LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
2,000,000
shares
|
$21 Million
10.64% of portfolio
|
Q2 2025
Added 10.38%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,692,413
shares
|
$17.8 Million
0.0% of portfolio
|
Q2 2025
Added 109.93%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
1,512,058
shares
|
$15.9 Million
0.01% of portfolio
|
Q2 2025
Reduced 50.94%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,297,982
shares
|
$13.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 35.2%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
1,264,997
shares
|
$13.3 Million
0.08% of portfolio
|
Q2 2025
New holding
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
1,253,344
shares
|
$13.2 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.73%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,242,927
shares
|
$13.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 54.93%
|
|
Adar1 Capital Management, LLC
Austin, TX |
Aug 14, 2025 Q2 2025 |
1,205,101
shares
|
$12.7 Million
1.18% of portfolio
|
Q2 2025
Reduced 18.11%
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,200,290
shares
|
$12.6 Million
0.04% of portfolio
|
Q2 2025
Reduced 25.42%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Aug 07, 2025 Q2 2025 |
1,154,485
shares
|
$12.1 Million
0.03% of portfolio
|
Q2 2025
Reduced 3.77%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,008,909
shares
|
$10.6 Million
0.0% of portfolio
|
Q2 2025
Added 285.4%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
820,164
shares
|
$8.62 Million
0.0% of portfolio
|
Q2 2025
Added 488.64%
|
|
Abrdn PLC
|
Jul 24, 2025 Q2 2025 |
738,657
shares
|
$7.76 Million
0.01% of portfolio
|
Q2 2025
Reduced 69.61%
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
732,256
shares
|
$7.7 Million
0.45% of portfolio
|
Q2 2025
Reduced 12.21%
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Aug 14, 2025 Q2 2025 |
650,000
shares
|
$6.83 Million
0.56% of portfolio
|
Q2 2025
New holding
|